Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy

BACKGROUND: Patients with peritoneal metastases from colorectal cancer have a poor prognosis. If the intraperitoneal tumour load is limited, patients may be eligible for cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). This treatment has improved overall survival,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ubink, I., Bolhaqueiro, A. C. F., Elias, S. G., Raats, D. A. E., Constantinides, A., Peters, N. A., Wassenaar, E. C. E., de Hingh, I. H. J. T, Rovers, K. P., van Grevenstein, W. M. U., Laclé, M. M., Kops, G. J. P. L., Borel Rinkes, I. H. M., Kranenburg, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771632/
https://www.ncbi.nlm.nih.gov/pubmed/31197820
http://dx.doi.org/10.1002/bjs.11206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771632/
https://www.ncbi.nlm.nih.gov/pubmed/31197820
http://dx.doi.org/10.1002/bjs.11206

Ejemplares similares